Full metadata record

DC Field Value Language
dc.contributor.authorHwang, Ho Seong-
dc.contributor.authorLee, Dahae-
dc.contributor.author손종대-
dc.contributor.authorJong-Gwon Beak-
dc.contributor.authorLee, Hyeon-Seong-
dc.contributor.author박인화-
dc.contributor.authorKim Dong Hoon-
dc.contributor.authorLee Soon Kwang-
dc.contributor.authorKim, Won Kyu-
dc.contributor.authorKwon, Hak Cheol-
dc.contributor.authorKang, Ki Sung-
dc.contributor.authorKwon, Jaeyoung-
dc.date.accessioned2024-01-12T06:36:22Z-
dc.date.available2024-01-12T06:36:22Z-
dc.date.created2023-04-05-
dc.date.issued2023-05-
dc.identifier.issn0045-2068-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/79940-
dc.description.abstractActinidia polygama has been used as a traditional medicine for treating various diseases. In the present study, 13 compounds, including three new monoterpenoids (1?3), were isolated from the leaves of A. polygama to investigate the bioactive constituents of the plant. The structures were characterized by analyzing spectroscopic and chiroptical data. These compounds were preliminarily screened for their ability to increase insulin secretion levels after glucose stimulation. Of these, 3-O-coumaroylmaslinic acid (4) and jacoumaric acid (5) showed activity. In further biological studies, these compounds exhibited increased glucose­stimulated insulin secretion (GSIS) activity without cytotoxicity in rat INS-1 pancreatic β-cells as well as α-glucosidase inhibitory activity. Furthermore, both compounds increased insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), pancreatic and duodenal homeobox-1 (PDX-1), and peroxisome proliferator-activated receptor-γ (PPAR-γ) expression. Hence, these compounds may be developed as potential antidiabetic agents.-
dc.languageEnglish-
dc.publisherAcademic Press-
dc.titleChemical constituents isolated from Actinidia polygama and their α-glucosidase inhibitory activity and insulin secretion effect-
dc.typeArticle-
dc.identifier.doi10.1016/j.bioorg.2023.106466-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBioorganic Chemistry, v.134-
dc.citation.titleBioorganic Chemistry-
dc.citation.volume134-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000953844600001-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaChemistry-
dc.type.docTypeArticle-
dc.subject.keywordPlusACTIVATED-RECEPTOR-GAMMA-
dc.subject.keywordPlusTYPE-2 DIABETES-MELLITUS-
dc.subject.keywordPlusBETA-CELL FUNCTION-
dc.subject.keywordPlusTHERAPIES-
dc.subject.keywordPlusPRODUCTS-
dc.subject.keywordPlusSURVIVAL-
dc.subject.keywordPlusARGUTA-
dc.subject.keywordPlusMASS-
dc.subject.keywordAuthorActinidia polygama-
dc.subject.keywordAuthorMonoterpenoid-
dc.subject.keywordAuthorTriterpenoid-
dc.subject.keywordAuthor?-glucosidase-
dc.subject.keywordAuthorInsulin secretion-
dc.subject.keywordAuthorAntidiabetic compound-
Appears in Collections:
KIST Article > 2023
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE